GEO Accession viewer

NCBI > GEO > Accession Display

Not logged in | Login

GEO help: Mouse over screen elements for information.

Sample GSM1098240

Query DataSets for GSM1098240

Status

Public on Apr 01, 2013

Title

METSIM1599

Sample type

SRA

Source name

adipose tissue

Organism

Homo sapiens

Characteristics

age: 55
tissue: adipose tissue
log10 body mass index: 1.367376327
log10 basal metabolic rate (kcal): 1545
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.617168971
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.647337353
plasma free fatty acids under the curve ogtt (mmol/l * min): 15.6
fat mass (%): 19.2
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.849405101
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 214.5
log10 homair (insulin resistance index based on homa): 0.12623967
log10 homais (insulin secretion index based on homa): 1.62838893
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.369549802
insgenin (insulinogenic index): 1.800631173
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.295479133
log10 matsuda insulin sensitivity index: 0.873622119
muscle mass (%): 45.8
lg10 serum c-reactive protein (mg/l): 0.725012725
lg10 plasma adiponectin (mg/l): 1.049218023
ogtt fasting plasma free fatty acid (mmol/l): 0.38
ogtt 30 min plasma free fatty acid (mmol/l): 0.15
ogtt 120 min plasma free fatty acid (mmol/l): 0.02
ogtt fasting plasma glucose (mmol/l): 5.9
ogtt 30 min plasma glucose (mmol/l): 9.1
ogtt 120 min plasma glucose (mmol/l): 6.4
log10 il1 receptor antagonist (pg/ml): 2.21285319
log10 il1 beta (pg/ml): -0.431798276
log10 ogtt fasting plasma insulin (mu/l): 0.707570176
ogtt 30 min plasma insulin (mu/l): 1.588831726
ogtt 120 min plasma insulin (mu/l): 1.522444234
log10 ogtt fasting plasma proinsulin (pm/l): 1.127104798
ogtt 30 min plasma proinsulin (pm/l): 1.359835482
ogtt 120 min plasma proinsulin (pm/l): 1.646403726
log10 bioimpedance: Resistance: 2.752048448
log10 bioimpedance (reactance): 1.785329835
waist to hip ratio: 0.909090909
log10 serum bilirubin (umol/l): 1.113943352
log10 serum alanine aminotransfrase (u/l): 1.255272505
log10 creatinine (umol/l): 1.880813592
log10 total cholesterol (mmol/l): 0.671172843
log10 ldl cholesterol (mmol/l): 0.338456494
log10 hdl cholesterol (mmol/l): 0.390935107
log10 total triglycerides (mmol/l): -0.207608311
log10 serum apoa1 (g/l): 0.222716471
log10 serum apob (g/l): -0.207608311
log10 urinary albumin excretion rate (ug/min): 0.879860146

Treatment protocol

We analyzed samples from 200 male human subjects that are part of the METSIM (METabolic Syndrome In Men) study. The population-based cross-sectional METSIM study included 10,197 men, aged from 45 to 73 years, who were randomly selected from the population register of the Kuopio town in eastern Finland (population 95,000). Every participant had a 1-day outpatient visit to the Clinical Research Unit at the University of Kuopio, including an interview on the history of previous diseases and current drug treatment and an evaluation of glucose tolerance and cardiovascular risk factors. After 12 hours of fasting, a 2-h oral 75-g glucose tolerance test was performed and the blood samples were drawn at 0, 30 and 120 min. Plasma glucose was measured by enzymatic hexokinase photometric assay (Konelab Systems reagents; Thermo Fischer Scientific, Vantaa, Finland). Insulin was determined by immunoassay (ADVIA Centaur Insulin IRI no. 02230141; Siemens Medical Solutions Diagnostics, Tarrytown, NY). Height and weight were measured to the nearest 0.5 cm and 0.1 kg, respectively. Waist (at the midpoint between the lateral iliac crest and lowest rib) and hip circumference (at the level of the trochanter major) were measured to the nearest 0.5 cm. Body composition was determined by bioelectrical impedance (RJL Systems) in subjects in the supine position after a 12-hour fast.

Extracted molecule

total RNA

Extraction protocol

Abdominal subcutaneous adipose tissue was obtained with needle biopsies. Total RNA was isolated from the adipose tissue using Qiagen miRNeasy kit according to manufacturer’s instructions. RNA Integrity Number (RIN) values were assessed with the Agilent Bioanalyzer 2100 instrument. Samples with RIN values greater than 7.0 were used for transcriptional profiling.
Small RNA libraries were prepared using the Illumina TruSeq Small RNA protocol utilizing up to 48 unique index sequences (Illumina Catalog Number FC-102-1009). For two samples (METSIM490 and METSIM6589) we also prepared small RNA libraries using Illumina Small RNA v1.5 sample preparation protocol (Catalog # FC-930-1501)

Library strategy

RNA-Seq

Library source

transcriptomic

Library selection

size fractionation

Instrument model

Illumina HiSeq 2000

Data processing

Illumina Casava1.7 software used for basecalling.
Sequencing files were converted to FASTQ format using a custom Perl script. In order to assign the indexed reads to each METSIM subject, a Python script was used to partition the FASTQ file for each lane into multiple FASTQ files, each of which corresponded to one individual. To be included in the partitioned file, a read had to have an exact match to one of the 48 possible index sequences, unambiguously identifying the individual from whom the read originated. Reads which did not exactly match an index sequence were discarded.
The reads were then aligned to the hg19 version of the genome using the Novoalign tool with the following settings: -l16 -t30 -h90 -rA -R 1 -m -g 200 –k. Novoalign software trims the adapter sequences while aligning.
We used the Bioconductor package GenomicRanges for R (v.2.14.0) to count the number of reads with alignment coordinates that overlap the coordinates of known mature miRNAs. Whenever a read mapped to 'x' genomic loci, the read would contribute a count of 1/x to those regions. The genomic coordinates for known mature miRNAs were downloaded from miRBase version 18.
To enable comparison of counts between samples, we normalized the expression values by dividing the counts for a given mature miRNA by the sum of all the miRNA counts for the corresponding individual. For subsequent analysis, we considered the expression levels of 356 miRNAs that had at least 5 reads in half of the study participants.
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include unnormalized weighted counts for each miRNA

Submission date

Mar 14, 2013

Last update date

May 15, 2019

Contact name

Mete Civelek

E-mail(s)

mcivelek@mednet.ucla.edu

Phone

310-825-1595

Fax

310-794-7345